COVID-19 LP.8.1 Vaccine Market Withdrawal
Health Canada has issued a market withdrawal of all COVID-19 LP.8.1 vaccines in Canada. The decision to withdraw all COVID-19 LP.8.1 vaccine products are part of Health Canada’s regulatory process to support the authorization of the updated Spikevax® and Comirnaty® Omicron XFG formulation for the upcoming fall 2026/27 respiratory illness season.
Effective immediately and as of September 21st, 2026, all remaining inventory must be either destroyed in accordance with local procedures or quarantined pending destruction. For sites that do not have these products on hand, no action is required.
For additional information and relevant vaccine resources, please visit Hamilton Public Health’s Health Care Provider webpage at www.hamilton.ca/HCP.
Please stay tuned for the implementation package related to the 2026/2027 fall respiratory programming including guidance for COVID-19, RSV and Flu programs and ordering for the 2026 fall respiratory season.
We thank you for your continued support and dedication to the publicly funded immunization program, protecting Hamiltonians against vaccine preventable diseases. If you or your staff have any questions, please contact Hamilton Public Health Vaccine Program at [email protected].
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
